These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8461978)

  • 1. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates.
    Hill JM; Mervis RF; Avidor R; Moody TW; Brenneman DE
    Brain Res; 1993 Feb; 603(2):222-33. PubMed ID: 8461978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systems.
    Brenneman DE; McCune SK; Mervis RF; Hill JM
    Adv Neuroimmunol; 1994; 4(3):157-65. PubMed ID: 7874383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia.
    Kanmogne GD; Kennedy RC; Grammas P
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):992-1000. PubMed ID: 12430716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells.
    Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE
    J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
    Habeshaw JA; Dalgleish AG; Bountiff L; Newell AL; Wilks D; Walker LC; Manca F
    Immunol Today; 1990 Nov; 11(11):418-25. PubMed ID: 2078296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gp160 of commercial HIV western blots is not gp160env. Should criteria for seropositivity be revised?
    Fenouillet E; Blanes N; Gluckman JC
    AIDS; 1991 Jun; 5(6):770. PubMed ID: 1883550
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-reactivity of anti-human immunodeficiency virus type 1 gp41 antibodies with human astrocytes and astrocytoma cell lines.
    Spehar T; Strand M
    J Virol; 1994 Oct; 68(10):6262-9. PubMed ID: 8083966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and detection of macrophage-tropic HIV-1 gp120 in the brain using conformation-dependent antibodies.
    Altmeyer R; Mordelet E; Girard M; Vidal C
    Virology; 1999 Jul; 259(2):314-23. PubMed ID: 10388656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures.
    Fitting S; Booze RM; Mactutus CF
    Brain Res; 2008 Sep; 1232():139-54. PubMed ID: 18674522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.
    Dibbern DA; Glazner GW; Gozes I; Brenneman DE; Hill JM
    J Clin Invest; 1997 Jun; 99(12):2837-41. PubMed ID: 9185505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.
    Graham BS; Matthews TJ; Belshe RB; Clements ML; Dolin R; Wright PF; Gorse GJ; Schwartz DH; Keefer MC; Bolognesi DP
    J Infect Dis; 1993 Mar; 167(3):533-7. PubMed ID: 8095059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
    Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
    J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist.
    Glowa JR; Panlilio LV; Brenneman DE; Gozes I; Fridkin M; Hill JM
    Brain Res; 1992 Jan; 570(1-2):49-53. PubMed ID: 1617429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.
    Moran LM; Fitting S; Booze RM; Webb KM; Mactutus CF
    Int J Dev Neurosci; 2014 Nov; 38():195-203. PubMed ID: 25285887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
    Dis Markers; 1991; 9(1):51. PubMed ID: 1742945
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal anti-idiotypes.
    Zaghouani H; Goldstein D; Shah H; Anderson S; Lacroix M; Dionne G; Kennedy R; Bona C
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5645-9. PubMed ID: 2062842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.